Laure Deville

705 total citations
13 papers, 202 citations indexed

About

Laure Deville is a scholar working on Geriatrics and Gerontology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Laure Deville has authored 13 papers receiving a total of 202 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Geriatrics and Gerontology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Laure Deville's work include Pharmaceutical Practices and Patient Outcomes (3 papers), Acute Myeloid Leukemia Research (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Laure Deville is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (3 papers), Acute Myeloid Leukemia Research (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). Laure Deville collaborates with scholars based in France, United States and Belgium. Laure Deville's co-authors include Josette Hillion, E. Segal, L. Iordache, Alfred Mahr, Pierre Faure, Jean‐Luc Moretti, Josette Brière, Marjan Ertault, Jérôme Larghero and Christian Gisselbrecht and has published in prestigious journals such as Cancer, AIDS and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Laure Deville

11 papers receiving 197 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laure Deville France 7 54 43 38 36 36 13 202
Mark Palangio United States 10 50 0.9× 20 0.5× 15 0.4× 7 0.2× 43 1.2× 15 365
Anupriya Kaur India 10 13 0.2× 7 0.2× 5 0.1× 65 1.8× 25 0.7× 60 246
Julien Guérin France 7 32 0.6× 7 0.2× 13 0.3× 23 0.6× 60 1.7× 26 178
Bisola Laguda United Kingdom 4 59 1.1× 4 0.1× 36 0.9× 71 2.0× 101 2.8× 5 249
Fabio Martino Doniselli Italy 11 19 0.4× 5 0.1× 26 0.7× 42 1.2× 15 0.4× 35 251
Wilhelm Geilen Germany 6 63 1.2× 5 0.1× 20 0.5× 71 2.0× 49 1.4× 6 240
Ji An Liang Taiwan 10 14 0.3× 15 0.3× 9 0.2× 53 1.5× 63 1.8× 21 266
Ernie Yap United States 8 13 0.2× 3 0.1× 14 0.4× 26 0.7× 23 0.6× 33 203
Patti Krautscheid United States 7 53 1.0× 13 0.3× 14 0.4× 70 1.9× 51 1.4× 9 298
Herbert Kappauf Germany 7 32 0.6× 7 0.2× 10 0.3× 19 0.5× 145 4.0× 21 304

Countries citing papers authored by Laure Deville

Since Specialization
Citations

This map shows the geographic impact of Laure Deville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laure Deville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laure Deville more than expected).

Fields of papers citing papers by Laure Deville

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laure Deville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laure Deville. The network helps show where Laure Deville may publish in the future.

Co-authorship network of co-authors of Laure Deville

This figure shows the co-authorship network connecting the top 25 collaborators of Laure Deville. A scholar is included among the top collaborators of Laure Deville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laure Deville. Laure Deville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kim, Esther, et al.. (2024). Réforme de l’accès dérogatoire : impact sur la gestion dans une PUI et identification des risques. Annales Pharmaceutiques Françaises. 82(4). 727–738.
2.
3.
Xhaard, Aliénor, Laure Deville, Matthieu Prot, et al.. (2024). Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant. International Journal of Antimicrobial Agents. 64(3). 107281–107281. 3 indexed citations
4.
Rubenstein, Emma, Myriam Diemer, Caroline Lascoux‐Combe, et al.. (2024). Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine. AIDS. 38(8). 1267–1269. 10 indexed citations
5.
Viglietti, Denis, Hélène Sauvageon, Denis Glotz, et al.. (2022). Adhésion médicamenteuse en greffe rénale : évaluation, facteurs prédictifs et impact sur l’allo-réactivité humorale. Annales Pharmaceutiques Françaises. 81(1). 152–162. 2 indexed citations
6.
Poirot, Brigitte, et al.. (2022). Rapid and long-lasting response to selpercatinib of paraneoplastic Cushing’s syndrome in medullary thyroid carcinoma. European Thyroid Journal. 11(6). 1 indexed citations
7.
Mahr, Alfred, et al.. (2017). Types, frequencies, and burden of nonspecific adverse events of drugs: analysis of randomized placebo‐controlled clinical trials. Pharmacoepidemiology and Drug Safety. 26(7). 731–741. 51 indexed citations
8.
Deville, Laure, et al.. (2017). Place du dossier pharmaceutique parmi les autres sources disponibles sur les traitements des patients à leur arrivée aux urgences. Le Pharmacien Hospitalier et Clinicien. 52(4). 383–383. 1 indexed citations
9.
Deville, Laure, et al.. (2011). hTERT Promotes Imatinib Resistance in Chronic Myeloid Leukemia Cells: Therapeutic Implications. Molecular Cancer Therapeutics. 10(5). 711–719. 19 indexed citations
10.
Deville, Laure, Josette Hillion, & E. Segal. (2009). Telomerase regulation in hematological cancers: A matter of stemness?. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1792(4). 229–239. 21 indexed citations
11.
Filmont, Jean‐Emmanuel, Christian Gisselbrecht, X. Cuenca, et al.. (2007). The impact of pre‐ and post‐transplantation positron emission tomography using 18‐fluorodeoxyglucose on poor‐prognosis lymphoma patients undergoing autologous stem cell transplantation. Cancer. 110(6). 1361–1369. 53 indexed citations
12.
Deville, Laure, Josette Hillion, Michel Lanotte, Philippe Rousselot, & E. Segal. (2006). Diagnostics, Prognostic and Therapeutic Exploitation of Telomeres and Telomerase in Leukemias. Current Pharmaceutical Biotechnology. 7(3). 171–183. 9 indexed citations
13.
Tabone‐Eglinger, Séverine, Agnieszka Woźniak, Raphaël Saffroy, et al.. (2005). KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1741(1-2). 165–172. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Palangio Breakdown of academic impact, for papers by Anupriya Kaur Breakdown of academic impact, for papers by Julien Guérin Breakdown of academic impact, for papers by Bisola Laguda Breakdown of academic impact, for papers by Fabio Martino Doniselli Breakdown of academic impact, for papers by Wilhelm Geilen Breakdown of academic impact, for papers by Ji An Liang Breakdown of academic impact, for papers by Ernie Yap Breakdown of academic impact, for papers by Patti Krautscheid Breakdown of academic impact, for papers by Herbert Kappauf
Rankless by CCL
2026